Geode Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.8B | Buy |
30,065,642
+339,590
| +1% | +$44.7M | 0.2% | 74 |
|
|
2026
Q1 | $4.14B | Buy |
29,726,052
+30,050
| +0.1% | +$4.21M | 0.26% | 58 |
|
|
2025
Q4 | $3.64B | Sell |
29,696,002
-232,984
| -0.8% | -$28.3M | 0.22% | 72 |
|
|
2025
Q3 | $3.31B | Buy |
29,928,986
+721,324
| +2% | +$82M | 0.21% | 78 |
|
|
2025
Q2 | $3.23B | Buy |
29,207,662
+727,515
| +3% | +$77.4M | 0.23% | 72 |
|
|
2025
Q1 | $3.19B | Buy |
28,480,147
+190,230
| +0.7% | +$19.6M | 0.25% | 68 |
|
|
2024
Q4 | $2.61B | Buy |
28,289,917
+749,047
| +3% | +$67.4M | 0.2% | 82 |
|
|
2024
Q3 | $2.3B | Buy |
27,540,870
+574,421
| +2% | +$43.8M | 0.19% | 93 |
|
|
2024
Q2 | $1.85B | Buy |
26,966,449
+617,094
| +2% | +$41.2M | 0.16% | 104 |
|
|
2024
Q1 | $1.93B | Buy |
26,349,355
+1,075,170
| +4% | +$82.7M | 0.18% | 102 |
|
|
2023
Q4 | $2.04B | Buy |
25,274,185
+578,546
| +2% | +$45M | 0.21% | 84 |
|
|
2023
Q3 | $1.85B | Buy |
24,695,639
+483,003
| +2% | +$37.2M | 0.22% | 83 |
|
|
2023
Q2 | $1.86B | Buy |
24,212,636
+447,585
| +2% | +$35.7M | 0.22% | 86 |
|
|
2023
Q1 | $1.97B | Sell |
23,765,051
-83,426
| -0.3% | -$6.91M | 0.26% | 75 |
|
|
2022
Q4 | $2.04B | Buy |
23,848,477
+244,886
| +1% | +$19.4M | 0.29% | 70 |
|
|
2022
Q3 | $1.45B | Buy |
23,603,591
+431,016
| +2% | +$27.2M | 0.22% | 82 |
|
|
2022
Q2 | $1.43B | Buy |
23,172,575
+468,908
| +2% | +$29M | 0.21% | 87 |
|
|
2022
Q1 | $1.35B | Sell |
22,703,667
-35,512
| -0.2% | -$2.27M | 0.17% | 103 |
|
|
2021
Q4 | $1.65B | Buy |
22,739,179
+440,695
| +2% | +$30.4M | 0.2% | 87 |
|
|
2021
Q3 | $1.55B | Buy |
22,298,484
+383,163
| +2% | +$26.9M | 0.21% | 85 |
|
|
2021
Q2 | $1.51B | Buy |
21,915,321
+1,244,015
| +6% | +$83.1M | 0.21% | 90 |
|
|
2021
Q1 | $1.33B | Buy |
20,671,306
+592,386
| +3% | +$38.2M | 0.2% | 92 |
|
|
2020
Q4 | $1.17B | Buy |
20,078,920
+76,942
| +0.4% | +$4.64M | 0.2% | 95 |
|
|
2020
Q3 | $1.26B | Buy |
20,001,978
+336,543
| +2% | +$23.3M | 0.25% | 73 |
|
|
2020
Q2 | $1.51B | Sell |
19,665,435
-217,073
| -1% | -$16.6M | 0.32% | 58 |
|
|
2020
Q1 | $1.48B | Buy |
19,882,508
+658,471
| +3% | +$45.5M | 0.39% | 50 |
|
|
2019
Q4 | $1.25B | Buy |
19,224,037
+535,813
| +3% | +$34.9M | 0.26% | 70 |
|
|
2019
Q3 | $1.18B | Buy |
18,688,224
+315,436
| +2% | +$20.6M | 0.28% | 66 |
|
|
2019
Q2 | $1.24B | Buy |
18,372,788
+751,923
| +4% | +$49.5M | 0.3% | 61 |
|
|
2019
Q1 | $1.14B | Buy |
17,620,865
+753,800
| +4% | +$50.1M | 0.3% | 63 |
|
|
2018
Q4 | $1.05B | Buy |
16,867,065
+835,915
| +5% | +$58.4M | 0.33% | 62 |
|
|
2018
Q3 | $1.24B | Buy |
16,031,150
+96,590
| +0.6% | +$7.29M | 0.35% | 56 |
|
|
2018
Q2 | $1.13B | Sell |
15,934,560
-1,093,008
| -6% | -$77.2M | 0.35% | 54 |
|
|
2018
Q1 | $1.28B | Buy |
17,027,568
+1,178,505
| +7% | +$93.7M | 0.42% | 44 |
|
|
2017
Q4 | $1.13B | Buy |
15,849,063
+379,867
| +2% | +$28.8M | 0.38% | 48 |
|
|
2017
Q3 | $1.25B | Buy |
15,469,196
+375,993
| +2% | +$28.8M | 0.46% | 40 |
|
|
2017
Q2 | $1.07B | Buy |
15,093,203
+676,105
| +5% | +$45M | 0.42% | 41 |
|
|
2017
Q1 | $978M | Buy |
14,417,098
+1,071,094
| +8% | +$75.3M | 0.4% | 42 |
|
|
2016
Q4 | $955M | Buy |
13,346,004
+637,314
| +5% | +$47.4M | 0.44% | 41 |
|
|
2016
Q3 | $1B | Buy |
12,708,690
+466,974
| +4% | +$37.9M | 0.51% | 36 |
|
|
2016
Q2 | $1.02B | Sell |
12,241,716
-169,130
| -1% | -$15M | 0.55% | 34 |
|
|
2016
Q1 | $1.14M | Buy |
12,410,846
+161,505
| +1% | +$14.6M | 0.6% | 30 |
|
|
2015
Q4 | $1.24B | Buy |
12,249,341
+104,895
| +0.9% | +$10.9M | 0.71% | 24 |
|
|
2015
Q3 | $1.19B | Buy |
12,144,446
+108,350
| +0.9% | +$12M | 0.72% | 22 |
|
|
2015
Q2 | $1.41B | Sell |
12,036,096
-142,972
| -1% | -$15.6M | 0.8% | 17 |
|
|
2015
Q1 | $1.19B | Buy |
12,179,068
+313,628
| +3% | +$31.8M | 0.68% | 23 |
|
|
2014
Q4 | $1.12B | Buy |
11,865,440
+463,779
| +4% | +$48M | 0.66% | 25 |
|
|
2014
Q3 | $1.21B | Sell |
11,401,661
-201,929
| -2% | -$19.8M | 0.79% | 20 |
|
|
2014
Q2 | $961M | Sell |
11,603,590
-135,653
| -1% | -$10.6M | 0.62% | 29 |
|
|
2014
Q1 | $831M | Buy |
11,739,243
+232,536
| +2% | +$18.2M | 0.56% | 31 |
|
|
2013
Q4 | $864M | Buy |
11,506,707
+409,251
| +4% | +$28.5M | 0.6% | 31 |
|
|
2013
Q3 | $697M | Buy |
11,097,456
+380,141
| +4% | +$22.7M | 0.56% | 33 |
|
|
2013
Q2 | $549M | Buy |
+10,717,315
| New | +$559M | 0.48% | 34 |
|
Other funds holding GILD
VCM
VPM
Geode Capital Management's GILD Position: Q2 2026 in Review
Geode Capital Management increased its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, buying an estimated $44.7M and bringing the position to 30,065,642 shares worth $3.8B. The position accounts for 0.2% of the portfolio, ranked #74.
Geode Capital Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.14B in Q1 2026. 1,917 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Geode Capital Management held 30,065,642 shares of Gilead Sciences worth $3.8B as of Q2 2026.
- Geode Capital Management bought 339,590 Gilead Sciences shares in Q2 2026, an estimated $44.7M.
- Gilead Sciences made up 0.2% of Geode Capital Management's portfolio in Q2 2026, its #74 holding.
- Geode Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Geode Capital Management's Gilead Sciences position peaked at $4.14B in Q1 2026.
- 1,917 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.